Magnetic resonance imaging for assessment of parametrial tumour spread and regression patterns in adaptive cervix cancer radiotherapy

References

• Boss EA, Barentsz JO, Massuger LFAG, Boonstra H. The role of MR imaging in invasive cervical carcinoma. Eur Radiol 2000;10:256–70.
   PubMed Web of Science ®Google Scholar
• Dimopoulos JCA, Petrow P, Tanderup K, Petric P, Berger D, Kirisits C, et al. Recommendations from Gynaecological (GYN) GEC_ESTRO Working Group (IV): Basic principles and parameters for MR imaging within the frame of image based adaptive cervix cancer brachytherapy. Radiother Oncol 2012;103:113–22.
   PubMed Web of Science ®Google Scholar
• Dimopoulos JCA, Schard G, Berger D, Lang S, Goldner G, Helbich T, et al. Systematic evaluation of MRI findings in different stages of treatment of cervical cancer: Potential of MRI on delineation of target, pathoanatomic structures, and organs at risk. Int J Radiat Oncol Biol Phys 2006;64: 1380–8.
   PubMed Web of Science ®Google Scholar
• Nicolet V, Carignan L, Bourdon F, Prosmanne O. MR imaging of cervical carcinoma: A practical staging approach. RadioGraphics 2000;20:1539–49.
   PubMed Web of Science ®Google Scholar
• Mayr NA, Tali ET, Yuh WT, Brown BP, Wen BC, Buller RE, et al. Cervical cancer: Application of MR imaging in radiation therapy. Radiology 1993;189:601–8.
   PubMed Web of Science ®Google Scholar
• Schmid MP, Mansmann B, Federico M, Dimopoulos JC, Georg P, Fidarova E, et al. Residual tumour volumes and grey zones after external beam radiotherapy (with or without chemotherapy) in cervical cancer patients. A low field MRI study. Strahlenther Onkol 2013;189:238–44.
   PubMed Web of Science ®Google Scholar
• Mayr NA, Taoka T, Yuh WT, Denning LM, Zhen WK, Paulino AC, et al. Method and timing of tumor volume measurement for outcome prediction in cervical cancer using magnetic resonance imaging. Int J Radiat Oncol Biol Phys 2002;52:14–22.
   PubMed Web of Science ®Google Scholar
• Wang JZ, Mayr NA, Zhang D, Li K, Grecula JC, Montebello JF, et al. Sequential magnetic resonance imaging of cervical cancer: The predictive value of absolute tumor volume and regression ratio measured before, during, and after radiation therapy. Cancer 2010; 116:5093–101.
   PubMedGoogle Scholar
• Hsu HC, Leung SW, Huang EY, Wang CJ, Sun LM, Fang FM, et al. Impact of the extent of parametrial involvement in patients with carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys 1998;40:405–10.
   PubMed Web of Science ®Google Scholar
• Kim YB, Lee IJ, Kim SY, Kim JW, Yoon HI, Kim SW, et al. Tumor heterogeneity of FIGO stage III carcinoma of the uterine cervix. Int Radiat Oncol Biol Phys 2009;75: 1323–8.
   PubMed Web of Science ®Google Scholar
• Pötter R, Georg P, Dimopulos JC, Grimm M, Berger D, Nesvacil N, et al. Clinical outcome of protocol based image (MRI) guided adaptive brachytherapy combined with 3D conformal radiotherapy with or without chemotherapy in patients with locally advanced cervical cancer. Radiother Oncol 2011;100:116–23.
   PubMed Web of Science ®Google Scholar
• Pötter R, Dimopoulos J, Georg P, Lang S, Waldhäusl C, Wachter-Gerstner N, et al. Clinical impact of MRI assisted dose volume adaptation and dose escalation in brachytherapy of locally advanced cervix cancer. Radiother Oncol 2007; 83:148–55.
   PubMed Web of Science ®Google Scholar
• Ebner F, Tamussino K, Kressek HY. Magnetic resonance imaging in cervical carcinoma: Diagnosis, staging, and follow-up. Magn Reson Q 1994;10:22–42.
   PubMedGoogle Scholar
• Chao KS, Williamson JF, Grigsby PW, Perez CA. Uterosacral space involvement in locally advanced carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys 1998;40:397–403.
   PubMed Web of Science ®Google Scholar
• Kundrat R. Über die Ausbreitung des Karzinoms im parametranen Gewebe beim Krebs des Collum uteri. Arch Gynäkol 1903;69:355–409.
   Google Scholar
• Ebner F, Tamussino K, Kressek HY. Magnetic resonance imaging in cervical carcinoma: Diagnosis, staging, and follow-up. Magn Reson Q 1994;10:22–42.
   PubMedGoogle Scholar
• Brunet G. Ergebnisse der abdominellen Radikaloperation des Gebärmutterscheidenkrebses mittels Laparotomia hypogastrica. Z Geburtshilfe Gynäkol 1905;56:1–87.
   Google Scholar
• Ober KG, Huhn FO. Die Ausbreitung des Cervixkrebses auf die Parametrien und die Lymphknoten der Beckenwand. Arch Gynäkol 1962;197:262–90.
   PubMedGoogle Scholar
• Mayr NA, Yuh WTC, Taoka T, Wang JZ, Wu DH, Montebello JF, et al. Serial therapy-induced changes in tumor shape in cervical cancer and their impact on assessing tumor volume and treatment response. AJR Am J Roentgenol 2006;187:65–72.
   PubMed Web of Science ®Google Scholar
• Haie-Meder C, Pötter R, Van Limbergen E, Briot E, De Brabandere M, Dimopoulos J, et al. Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (I): Concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV. Radiother Oncol 2005;74:235–45.
   PubMed Web of Science ®Google Scholar
• Höckel M, Schlenger K, Aral B, Mitze M, Schaffer U, Vaupel P. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res 1996;56:4509–15.
   PubMed Web of Science ®Google Scholar
• Schmid MP, Kirisits C, Nesvacil N, Dimopoulos JC, Berger D, Pötter R. Local recurrences in cervical cancer patients in the setting of image-guided brachytherapy: A comparison of spatial dose distribution within a matched pair analysis. Radiother Oncol 2011;100:468–72.
   PubMed Web of Science ®Google Scholar
• Pötter R, Kirisits C, Fidarova EF, Dimopoulos JC, Berger D, Tanderup K, et al. Present status and future of high-precision image guided adaptive brachytherapy for cervix carcinoma. Acta Oncol 2008;47:1325–36.
   PubMed Web of Science ®Google Scholar
• Kaplan HS. Hodgkin's disease, 2nd ed. Cambridge, MA: Harvard University Press; 1980. p. 281–339.
   Google Scholar
• Kazawa N, Kitaichi M, Hiraoka M, Togashi K, Mio N, Mishima M, et al. Small cell lung carcinoma: Eight types of extension and spread on computed tomography. J Comput Assist Tomogr 2006;30:653–61.
   PubMed Web of Science ®Google Scholar
• Diehn M, Nardini C, Wang DS, McGovern S, Jayaraman M, Liang Y, et al. Identification of noninvasive imaging surrogates for brain tumour gene-expression modules. Proc Natl Acad Sci USA 2008;105:5213–8.
   PubMed Web of Science ®Google Scholar
• Hompland T, Ellingsen C, Galappathi K, Rofstad EK. Connective tissue of cervical carcinoma xenografts: Associations with tumor hypoxia and interstitial fluid pressure and its assessment by DCE-MRI and DW-MRI. Acta Oncol Epub2013 Feb 27.
   Google Scholar
• Andersen EK, Kristensen GB, Lyng H, Malinen E. Pharmacokinetic analysis and k-means clustering of DCEMR images for radiotherapy outcome prediction of advanced cervical cancers. Acta Oncol 2011;50:859–65.
   PubMed Web of Science ®Google Scholar
• Schütz M, Schmid MP, Pötter R, Kommata S, Georg D, Lukic D, et al. Evaluating repetitive 18F-fluoroazomycin-arabinosode (18FAZA) PET in the setting of MRI guided adaptive radiotherapy in cervical cancer. Acta Oncol 2010;49:941–7.
   PubMed Web of Science ®Google Scholar
• Haack S, Pedersen EM, Jespersen SN, Kallehauge JF, Lindegaard JC, Tanderup K. Apparent diffusion coefficients in GEC ESTRO target volumes for image guided adaptive brachytherapy of locally advanced cervical cancer. Acta Oncol 2010;49:978–83.
   PubMed Web of Science ®Google Scholar
• Zahra MA, Tan LT, Priest AN, Graves MJ, Arends M, Crawford RA, et al. Semiquantitative and quantitative dynamic contrast-enhanced magnetic resonance imaging measurements predict radiation response in cervix cancer. Int J Radiat Oncol Biol Phys 2009;74:766–73.
   PubMed Web of Science ®Google Scholar
• Mayr NA, Wang JZ, Zhang D, Grecula JC, Lo SS, Jaroura D, et al. Longitudinal changes in tumor perfusion pattern during the radiation therapy course and its clinical impact in cervical cancer. Int J Radiat Oncol Biol Phys 2010;77:502–8.
   PubMed Web of Science ®Google Scholar
• Mayr NA, Huang Z, Wang JZ, Lo SS, Fan JM, Grecula JC, et al. Characterizing tumor heterogeneity with functional imaging and quantifying high-risk tumor volume for early prediction of treatment outcome: Cervical cancer as a model. Int J Radiat Oncol Biol Phys 2012;83:972–9.
   PubMed Web of Science ®Google Scholar